390 related articles for article (PubMed ID: 19929825)
21. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
[TBL] [Abstract][Full Text] [Related]
22. ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd H; Gifford E
Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
[TBL] [Abstract][Full Text] [Related]
23. Recent advances on aqueous solubility prediction.
Wang J; Hou T
Comb Chem High Throughput Screen; 2011 Jun; 14(5):328-38. PubMed ID: 21470182
[TBL] [Abstract][Full Text] [Related]
24. In silico ADME/Tox: the state of the art.
Ekins S; Rose J
J Mol Graph Model; 2002 Jan; 20(4):305-9. PubMed ID: 11858639
[TBL] [Abstract][Full Text] [Related]
25. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.
Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM
Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713
[TBL] [Abstract][Full Text] [Related]
26. In silico predictions of ADME-Tox properties: drug absorption.
Geerts T; Vander Heyden Y
Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
[TBL] [Abstract][Full Text] [Related]
27. Predicting ADME properties in silico: methods and models.
Butina D; Segall MD; Frankcombe K
Drug Discov Today; 2002 Jun; 7(11):S83-8. PubMed ID: 12047885
[TBL] [Abstract][Full Text] [Related]
28. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
Moda TL; Torres LG; Carrara AE; Andricopulo AD
Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
[TBL] [Abstract][Full Text] [Related]
29. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.
Clark AM; Dole K; Coulon-Spektor A; McNutt A; Grass G; Freundlich JS; Reynolds RC; Ekins S
J Chem Inf Model; 2015 Jun; 55(6):1231-45. PubMed ID: 25994950
[TBL] [Abstract][Full Text] [Related]
30. The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.
Komura H; Watanabe R; Mizuguchi K
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004597
[TBL] [Abstract][Full Text] [Related]
31. ADME-Space: a new tool for medicinal chemists to explore ADME properties.
Bocci G; Carosati E; Vayer P; Arrault A; Lozano S; Cruciani G
Sci Rep; 2017 Jul; 7(1):6359. PubMed ID: 28743970
[TBL] [Abstract][Full Text] [Related]
32. The importance of HT-ADME in drug discovery.
Morgan D
Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
Tsaioun K; Blaauboer BJ; Hartung T
ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
[TBL] [Abstract][Full Text] [Related]
34. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans.
Klopman G; Stefan LR; Saiakhov RD
Eur J Pharm Sci; 2002 Dec; 17(4-5):253-63. PubMed ID: 12453615
[TBL] [Abstract][Full Text] [Related]
35. ADME-Tox in drug discovery: integration of experimental and computational technologies.
Yu H; Adedoyin A
Drug Discov Today; 2003 Sep; 8(18):852-61. PubMed ID: 12963322
[TBL] [Abstract][Full Text] [Related]
36. QSPR in oral bioavailability: specificity or integrality?
Cabrera-Pérez MÁ; Pham-The H; Bermejo M; Álvarez IG; Álvarez MG; Garrigues TM
Mini Rev Med Chem; 2012 Jun; 12(6):534-50. PubMed ID: 22587767
[TBL] [Abstract][Full Text] [Related]
37. Drug metabolism and pharmacokinetics in drug discovery.
Roberts SA
Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
[TBL] [Abstract][Full Text] [Related]
38. Estimation of ADME properties with substructure pattern recognition.
Shen J; Cheng F; Xu Y; Li W; Tang Y
J Chem Inf Model; 2010 Jun; 50(6):1034-41. PubMed ID: 20578727
[TBL] [Abstract][Full Text] [Related]
39. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
Khan MT; Sylte I
Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
[TBL] [Abstract][Full Text] [Related]
40. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
